--> --> -->

Global Liquid Biopsy Market Analysis, 2020

By Work Process (Sample Preparation, Library Preparation, Sequencing, Data Analysis), By Technology (PCR [RT-PCR, dPCR, Multiplex PCR, Others], NGS, FISH, Other Technologies), By Usage (RUO, Clinical), By Sample Type (Blood, Urine, Saliva, CerebroSpinal Fluid), By Product (Test /Services, Kits and Consumables, Instruments), By Circulating Biomarkers (Circulating Tumor Cells, Cell-free DNA, Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Others), By Disease Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Other Cancers, Non-Oncology Disorders), By Clinical Application (Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection, Diagnosis and Screening), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, China, Japan, South Korea, India, South East Asia), By Company (Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. etc.)

  • Healthcare
  • Oct 2020
  • 182
  • HC22048